Pear Therapeutics, Inc. (PEAR): Price and Financial Metrics
PEAR Price/Volume Stats
| Current price | $0.03 | 52-week high | $6.74 |
| Prev. close | $0.05 | 52-week low | $0.03 |
| Day low | $0.03 | Volume | 66,303,200 |
| Day high | $0.04 | Avg. volume | 7,748,841 |
| 50-day MA | $0.62 | Dividend yield | N/A |
| 200-day MA | $1.49 | Market Cap | 4.17M |
PEAR Stock Price Chart Interactive Chart >
Pear Therapeutics, Inc. (PEAR) Company Bio
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
PEAR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -99.50% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -80.97% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...